Skip to main content
Log in

Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma

  • Gastrointestinal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

The purpose of this study was to assess the quality of biliary duct visualization using Gd-EOB-DTPA-enhanced magnetic resonance cholangiography (EOB-MRC) in patients with liver cirrhosis. Forty adult patients with liver cirrhosis (cirrhosis group) and 20 adult individuals with normal liver parenchyma (control group) underwent EOB-MRC using T1-weighted GRE imaging up to 180 min after Gd-EOB-DTPA administration. Two observers assessed the visualization of each biliary structure and the overall anatomical visualization of the biliary tree. Child-Pugh, MELD score and laboratory findings were compared. The grade of visualization for each evaluated biliary structure was statistically different in the two groups (P = 0.004 to <0.001). The overall EOB-MRC quality was rated as sufficient for anatomical visualization of the biliary tree in all individuals of the control group 20 min after Gd-EOB-DTPA application, but in only 16/40 patients (40%) of the cirrhosis group within 30 min after application. Analysis of the ROC curves revealed that the cut-off values, for non-sufficient visualization of the biliary tree 20 min after Gd-EOB-DTPA application, were MELD scores ≥11 and total serum bilirubin levels ≥30 μmol/l. Consecutively, EOB-MRC in patients with liver cirrhosis resulted in a decreased or even non-visualization of the biliary tree in a substantial percentage of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1a–f
Fig. 2a–c
Fig. 3a–h
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. An SK, Lee JM, Suh KS, Lee NJ, Kim SH, Kim YJ, Han JK, Choi BI (2006) Gadobenate dimeglumine-enhanced liver MRI as the sole preoperative imaging technique: a prospective study of living liver donors. AJR Am J Roentgenol 187:1223–1233

    Article  PubMed  Google Scholar 

  2. Carlos RC, Hussain HK, Song JH, Francis IR (2002) Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol 179:87–92

    PubMed  Google Scholar 

  3. Lee VS, Krinsky GA, Nazzaro CA, Chang JS, Babb JS, Lin JC, Morgan GR, Teperman LW (2004) Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. Radiology 233:659–666

    Article  PubMed  Google Scholar 

  4. Pilleul F, Billaud Y, Gautier G, Monneuse O, Crombe-Ternamian A, Fouque P, Valette PJ (2004) Mangafodipir-enhanced magnetic resonance cholangiography for the diagnosis of bile duct leaks. Gastrointest Endosc 59:818–822

    Article  PubMed  Google Scholar 

  5. Vitellas KM, El-Dieb A, Vaswani KK, Bennett WF, Fromkes J, Ellison C, Bova JG (2002) Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients. AJR Am J Roentgenol 179:409–416

    PubMed  Google Scholar 

  6. Aduna M, Larena JA, Martin D, Martinez-Guerenu B, Aguirre I, Astigarraga E (2005) Bile duct leaks after laparoscopic cholecystectomy: value of contrast-enhanced MRCP. Abdom

    Article  PubMed  CAS  Google Scholar 

  7. Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ (1997) Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 7:126–132

    Article  PubMed  CAS  Google Scholar 

  8. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR (2002) Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol 9:1322–1325

    Article  PubMed  Google Scholar 

  9. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792

    PubMed  CAS  Google Scholar 

  10. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699

    Article  PubMed  CAS  Google Scholar 

  11. Lee VS, Rofsky NM, Morgan GR, Teperman LW, Krinsky GA, Berman P, Weinreb JC (2001) Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy. AJR Am J Roentgenol 176:906–908

    PubMed  CAS  Google Scholar 

  12. Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, Kim YS, Kang DS (2004) Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol 5:231–239

    Article  PubMed  Google Scholar 

  13. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124:91–96

    Article  PubMed  Google Scholar 

  14. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank T. C. Tschirch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tschirch, F.T.C., Struwe, A., Petrowsky, H. et al. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 18, 1577–1586 (2008). https://doi.org/10.1007/s00330-008-0929-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-008-0929-6

Keywords

Navigation